6/16/21-Collaborative Care: Addressing SUD Related Physical Co-Morbidities
Presentation Resources
Butner, 2017 abstract only
https://www.journalofsubstanceabusetreatment.com/article/S0740-5472(16)30321-X/fulltextCDC. Diagnoses of HIV infection in the United States and dependent areas, 2018 (updated). HIV Surveillance Report 2020;31
https://www.cdc.gov/hiv/pdf/library/reports/surveillance/cdc-hiv-surveillance-report-2018-updated-vol-31.pdfCDC. Testing for HCV infection: An update of guidance for clinicians and laboratorians. MMWR. 2013;62(18).
https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6218a5.htmCenters for Disease Control and Prevention. 2019 Viral Hepatitis Surveillance Report
Centers for Disease Control and Prevention. 2019 Viral Hepatitis Surveillance Report.
https://www.cdc.gov/hepatitis/statistics/SurveillanceRpts.htm. Published July 2021.Degenhardt L, Hall W. Lancet 2012.
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(11)61138-0/fulltextHolmberg SD, et al. N Engl J Med. 2013;368:1859-61
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5672915/Mehta et al., 2008
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3800027/NIDA. 2020, April 9. Part 2: Co-occurring Substance Use Disorder and Physical Comorbidities. Retrieved from
https://www.drugabuse.gov/publications/research-reports/common-comorbidities-substance-use-disorders/part-2-co-occurring-substance-use-disorder-physical-comorbiditiesNjoroge LW, et al.. JAMA Cardiol 2018
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6143071/O’Brien et al. Transfusion 2007 abstract only
O’Brien et al. Transfusion 2007
abstract only
https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1537-2995.2007.01108.xOramasionwu, Moore, & Toliver, 2014
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4011402/Public Health Agency of Canada, HIV Transmission Risk: A Summary of Evidence
https://www.catie.ca/sites/default/files/HIV-TRANSMISSION-RISK-EN.pdfRonan MV, Herzig SJ. Health Aff (Milwood) 2016
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5240777/Rogers A.H., Wieman S.T., Baker A.W. (2020) Anxiety Comorbidities: Mood Disorders, Substance Use Disorders, and Chronic Medical Illness. In: Bui E., Charney M., Baker A. (eds) Clinical Handbook of Anxiety Disorders. Current Clinical Psychiatry. Humana, Ch
Abstract only
https://doi.org/10.1007/978-3-030-30687-8_5Akuko Wakuta etc, Hepatobiliary and pancreas. 73(6), 979-984. 2016
Walker, E. R. & Druss, B. G. (2017). Cumulative burden of comorbid mental disorders, substance use disorders, chronic medical conditions, and poverty on health among adults in the U.S.A.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5564203/Wolfe et al., 2015;
Wu, L. T., Ghitza, U. E., Zhu, H., Spratt, S., Swartz, M., & Mannelli, P. (2018). Substance use disorders and medical comorbidities among high-need, high-risk patients with diabetes. Drug and alcohol dependence, 186, 86–93.
https://doi.org/10.1016/j.drugalcdep.2018.01.008
https://www.researchgate.net/publication/323544498_Substance_use_disorders_and_medical_comorbidities_among_high-need_high-risk_patients_with_diabetes
Related Resources
International development and psychometric properties of the Child and Adolescent Trauma Screen (CATS)
https://pubmed.ncbi.nlm.nih.gov/28049104/Trauma-Focused Cognitive Behavior Therapy
https://www.tfcbt.org/TBRI Systematic Review
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3877861/Cannabis Withdrawal Scale
https://insight.qld.edu.au/shop/cannabis-withdrawal-scale-cws-insight-2019